All Web Images Videos News
Settings
Appearance
Site Icons
Font Size
Font
General
Infinite Scroll
Open Links in a New Tab
Safe Search
Search Engine Optimization Overview
86
100
Home | GSK
At GSK, we unite science, technology and talent to get ahead of disease together
https://www.gsk.com/en-gb/
1 high issue
3.0%
3 medium issues
9.1%
4 low issues
12.1%
25 tests passed
75.8%
0.15 seconds
253.69 kB
19 resources
Secure
Seo
Title
The title tag is perfect.
Home | GSK
Meta description
The meta description tag is good.
At GSK, we unite science, technology and talent to get ahead of disease together
Headings
The headings are properly set.
  1. Behind the science
  1. Finding new ways to treat and prevent HIV
  2. Our strategy
  3. Discover how we're getting ahead
  4. How we help people thrive 
  5. Outstanding people
  6. Positively impacting society and the planet
  7. In the spotlight
  8. London
  9. NYSE
  10. GSK on social
  1. We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.
  2. Eosinophils could be holding the missing link between symptoms, diagnosis and treatment
  3. Time for a change: personalising asthma treatment
  4. Unlocking the power of the immune system to get ahead of hepatitis B
  5. Tackling tomorrow’s health challenges today
  6. How vaccine science can help tackle antimicrobial resistance
  7. The 40 year fight against HIV
  8. How the next generation of immuno-oncology could help us get ahead of cancer
  9. 1.4 million reasons to get ahead of gynaecologic cancers
  10. Digital twin: using advanced technology to accelerate vaccine development
  11. What if remission were the target of lupus care?
  12. Culture
  14. Growth
  15. Diversity, equity and inclusion
  16. Wellbeing
  17. Pricing and access
  18. Global health and health security
  19. Diversity, equity and inclusion
  20. Environmental sustainability
  21. Product governance
  22. Ethical standards
  23. MEDIA
  24. MEDIA
  25. INVESTORS
  26. Share price at 31 October 2022 10:19
  27. Share price at 28 October 2022 17:00
  28. INVESTORS
  1. Behind the science
  2. Life at GSK
Content keywords
The content has relevant keywords.
gsk
Image keywords
All images have alt attributes set.
SEO friendly URL
The URL is SEO friendly.
https://www.gsk.com/en-gb/
404 page
The website has 404 error pages.
https://www.gsk.com/404-1e8db610b3773d3002386358ecdd9735
Robots.txt
The webpage can be accessed by search engines.
Noindex
The webpage does not have a noindex tag set.
In-page links
The webpage contains more than 150 links.
  1. Change location
  2. Contact us Contact us
  3. Search
  4. GSK logo linking to the homepage
  5. Behind the science magazine
  6. Behind the science magazine
  7. Behind the science magazine
  8. Company
  9. Company
  10. Company
  11. Purpose, strategy and culture
  12. Outstanding people
  13. Outstanding people
  14. Working together
  15. My GSK story
  16. Innovating together 2022
  17. Innovating together 2021
  18. GSK at a glance
  19. History and heritage
  20. Board of directors and leadership team
  21. Board information
  22. Governance
  23. Governance
  24. Committees
  25. Shareholders
  26. Sarbanes-Oxley Act 2002
  27. Compliance
  28. Policy positions
  29. Codes, standards and reports
  30. FEATURED SECTION Our purpose, strategy and culture
  31. FEATURED SECTION Outstanding people
  32. Innovation
  33. Innovation
  34. Innovation
  35. Research and development approach
  36. Pipeline
  37. Therapeutic areas
  38. Therapeutic areas
  39. Infectious diseases
  40. HIV
  41. Oncology
  42. Immunology
  43. Opportunity-driven
  44. Technologies
  45. Clinical trials at GSK
  46. Clinical trials at GSK
  47. Provision of unlicensed medicines for unmet medical needs
  48. Data transparency
  49. Diversity in clinical trials
  50. Partnering with GSK
  51. Partnering with GSK
  52. Supported studies
  53. R&D locations
  54. SPOTLIGHT ON Behind the science magazine
  55. FEATURED SECTION Oncology
  56. Products
  57. Products
  58. Products
  59. Our product areas
  60. Products A-Z
  61. SPOTLIGHT ON Innovation
  62. Responsibility
  63. Responsibility
  64. Responsibility
  65. Pricing and access
  66. Global health and health security
  67. Global health and health security
  68. Global health
  69. Health security
  70. Using our science for global health
  71. Improving access to healthcare
  72. Diversity, equity and inclusion
  73. Environmental sustainability
  74. Environmental sustainability
  75. Climate
  76. Water
  77. Materials and waste
  78. Biodiversity
  79. Product governance
  80. Ethical standards
  81. Ethical standards
  82. Working with third parties
  83. Public policy and patient advocacy
  84. Human rights
  85. Use of animals
  86. Engaging with healthcare professionals
  87. Charitable partnerships
  88. ESG resources
  89. ESG resources
  90. ESG Reports archive
  91. FEATURED SECTION Diversity equity and inclusion
  92. SPOTLIGHT ON Our policy positions
  93. Investors
  94. Investors
  95. Investors
  96. Why invest in GSK?
  97. Quarterly results
  98. Financial reports
  99. Financial reports
  100. Annual Report 2021
  101. Corporate reports archive
  102. Speeches and presentations
  103. Dividend and share price
  104. Dividend and share price
  105. GSK share price
  106. Share price calculators (GBp/USD)
  107. Dividend calculators (GBp/USD)
  108. Dividend calendar
  109. Events calendar
  110. Analyst consensus
  111. Stock exchange announcements
  112. Stock exchange announcements
  113. London (RNS)
  114. London (RNS) inside information
  115. New York (SEC)
  116. Sign up for announcements
  117. Shareholder information
  118. Shareholder information
  119. Manage your shares
  120. Annual General Meeting
  121. General Meeting
  122. Annual Governance Meeting
  123. Corporate sponsored nominee service
  124. Our ADR programme
  125. Asset reunification - ProSearch
  126. Share scam alert
  127. Privacy notice for ordinary shareholders
  128. FAQs
  129. Corporate actions
  130. Corporate actions
  131. Consumer Healthcare Demerger
  132. Consumer Healthcare Joint Venture
  133. Agreement to acquire TESARO
  134. Debt investors
  135. Investors contact details
  136. SPOTLIGHT ON Press releases
  137. SPOTLIGHT ON Our pipeline
  138. Media
  139. Media
  140. Media
  141. Press releases
  142. Media contacts
  143. Conferences
  144. Media library
  145. Our response to the situation in Ukraine
  146. Our response to COVID-19
  147. Our social media
  148. RSS feeds
  149. FEATURED SECTION Behind the science magazine
  150. SPOTLIGHT ON Our response to Covid
  151. Careers
  152. Careers
  153. Careers
  154. Search jobs
  155. Featured careers
  156. Featured careers
  157. A career in GSK Renal
  158. Life at GSK
  159. Experienced professionals
  160. Experienced professionals
  161. Business Operations
  162. Engineering at GSK
  163. Manufacturing and supply
  164. Marketing and sales
  165. Research and development
  166. Research and development
  167. Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS)
  168. Genomic sciences
  169. Technology
  170. Early talent
  171. Early talent
  172. Kickstart your career
  173. Apprentice programmes
  174. Work experience, placements and internships
  175. Future leaders graduate programme
  176. Future leaders graduate programme
  177. Business operations
  178. Engineering
  179. Manufacturing Operations, Quality & Logistics
  180. Marketing and sales
  181. Research and development
  182. Technology
  183. Post graduate opportunities
  184. Our global and regional hubs
  185. How we hire
  186. How we hire
  187. Frequently asked questions
  188. Fraudulent internet recruitment activities
  189. FEATURED SECTION Outstanding people
  190. FEATURED SECTION Diversity equity and inclusion
  191. Contact us Contact us
  192. Read article
  193. Purpose, strategy and culture
  194. Why invest in GSK?
  195. Go to infectious diseases
  196. Go to HIV
  197. Go to oncology
  198. Go to immunology
  199. Eosinophils could be holding the missing link between symptoms, diagnosis and treatment
  200. Time for a change: personalising asthma treatment
  201. Unlocking the power of the immune system to get ahead of hepatitis B
  202. Tackling tomorrow’s health challenges today
  203. How vaccine science can help tackle antimicrobial resistance
  204. The 40 year fight against HIV
  205. How the next generation of immuno-oncology could help us get ahead of cancer
  206. 1.4 million reasons to get ahead of gynaecologic cancers
  207. Digital twin: using advanced technology to accelerate vaccine development
  208. What if remission were the target of lupus care?
  209. Read our magazine
  210. The Code
  211. Purpose, strategy and culture
  212. Life at GSK
  213. Diversity, equity and inclusion
  214. Life at GSK
  215. Careers at GSK
  216. INNOVATING TOGETHER 2022 Meet Mugdha: working together to help more patients
  217. WORKING TOGETHER Meet Tim: valuing neurodiversity in Global Health
  218. WORKING TOGETHER Meet Fiona: improving health and wellbeing through nature
  219. WORKING TOGETHER Meet Andy: how a life-changing diagnosis changed his career
  220. MY GSK STORY Meet Alison: taking pride in working for GSK
  221. INNOVATING TOGETHER 2022 Meet Pal: combining the power of genetics and genomics
  222. View all series
  223. Pricing and access
  224. Global health and health security
  225. Diversity, equity and inclusion
  226. Environmental sustainability
  227. Product governance
  228. Ethical standards
  229. MEDIA GSK and Microsoft, in collaboration with the Centre for Health and Disease Studies, launch disease surveillance project in Nepal
  230. MEDIA GSK launches Sustainable Procurement Programme for suppliers
  231. INVESTORS Access all documents and information relating to the demerger
  232. Go to calculator
  233. Go to calculator
  234. View latest results
  235. Continue to Company
  236. GSK
  237. location selector. 
  238. Modern Slavery Act statement 2021 (PDF - 211.0KB)
  239. Locations selector
  240. Behind the science magazine
  241. Company
  242. Innovation
  243. Products
  244. Responsibility
  245. Investors
  246. Media
  247. Careers
  248. Contact us
  249. Partnerships
  250. Report a possible side effect
  251. Accessibility
  252. Terms of use
  253. Cookie policy
  254. Sitemap
Language
The webpage has the language declared.
en-GB
Favicon
The webpage has a favicon.
https://www.gsk.com/assets/img/favicons/apple-touch-icon-152x152.png?v=1507259205
Performance
Text compression
The HTML file is not compressed.
Load time
The webpage loaded in 0.15 seconds.
Page size
The size of the HTML webpage is 253,686.00.
HTTP requests
There are fewer than 19 HTTP requests on the webpage.
  1. https://www.gsk.com/assets/js/min/scripts.min.js?v=1507259205
  1. https://www.gsk.com/assets/css/styles.css?v=1507259205
  1. https://www.gsk.com/media/8512/web08-header-dna_science.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  2. https://www.gsk.com/media/9354/trust_nicola_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  3. https://www.gsk.com/media/9383/behind_the_science_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  4. https://www.gsk.com/media/8396/immuno_oncology_octane_ry_6k_still_1280x720px.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  5. https://www.gsk.com/media/9347/web03-header-stvg_2_2022_port_5_hess_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  6. https://www.gsk.com/media/9295/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  7. https://www.gsk.com/media/9346/web16-header-stvg_2_2022_port_13_hess_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  8. https://www.gsk.com/media/9345/gsk_texture_fluid_03_a_cmyk_web-size_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  9. https://www.gsk.com/media/9351/ware_3_2022_prodassmb_28_hess_nav.jpeg?mode=stretch&width=329&height=185&bgcolor=fff
  10. https://www.gsk.com/media/9350/ware_3_2022_prodqc_14_hess.jpeg?mode=stretch&width=329&height=185&bgcolor=fff
  11. https://www.gsk.com/media/9383/behind_the_science_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  12. https://www.gsk.com/media/8388/covid_crosssection_octane_ry_6k_still_1280x720px.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  13. https://www.gsk.com/media/9354/trust_nicola_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  14. https://www.gsk.com/media/9346/web16-header-stvg_2_2022_port_13_hess_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  1. https://videos.gskinternet.com/corporate/gskmedialibrary/HIV_Octane_RY_16x9.mp4
  2. https://videos.gskinternet.com/corporate/gskmedialibrary/HIV_Octane_RY_16x9.mp4
  3. https://videos.gskinternet.com/corporate/gskmedialibrary/gsk_hiv_science_aa_ani.mp4
Image format
There are 47 images that are not using the AVIF, WebP format.
  1. https://www.gsk.com/media/8512/web08-header-dna_science.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  2. https://www.gsk.com/media/9354/trust_nicola_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  3. https://www.gsk.com/media/9383/behind_the_science_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  4. https://www.gsk.com/media/8396/immuno_oncology_octane_ry_6k_still_1280x720px.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  5. https://www.gsk.com/media/9347/web03-header-stvg_2_2022_port_5_hess_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  6. https://www.gsk.com/media/9295/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  7. https://www.gsk.com/media/9346/web16-header-stvg_2_2022_port_13_hess_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  8. https://www.gsk.com/media/9345/gsk_texture_fluid_03_a_cmyk_web-size_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  9. https://www.gsk.com/media/9351/ware_3_2022_prodassmb_28_hess_nav.jpeg?mode=stretch&width=329&height=185&bgcolor=fff
  10. https://www.gsk.com/media/9350/ware_3_2022_prodqc_14_hess.jpeg?mode=stretch&width=329&height=185&bgcolor=fff
  11. https://www.gsk.com/media/9383/behind_the_science_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  12. https://www.gsk.com/media/8388/covid_crosssection_octane_ry_6k_still_1280x720px.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  13. https://www.gsk.com/media/9354/trust_nicola_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  14. https://www.gsk.com/media/9346/web16-header-stvg_2_2022_port_13_hess_nav.jpg?mode=stretch&width=329&height=185&bgcolor=fff
  15. https://www.gsk.com/media/8390/gsk_eosinophils_rgb_1280x720px.jpg?anchor=center&mode=crop&quality=90&width=300&height=375&rnd=133013493690000000
  16. https://www.gsk.com/media/9439/gskh_3_2022_comspc_23_hess.jpg?center=0.195,0.50166666666666671&mode=crop&quality=90&width=300&height=375&rnd=133059046440000000
  17. https://www.gsk.com/media/7703/stvg_2_2022_smtlab_15_hess.jpeg?anchor=center&mode=crop&quality=90&width=300&height=375&rnd=133020922890000000
  18. https://www.gsk.com/media/8845/ware_3_2022_prodqc_21_hess.jpeg?anchor=center&mode=crop&quality=90&width=300&height=375&rnd=133020922890000000
  19. https://www.gsk.com/media/7711/ware_3_2022_prodqc_10_hess.jpg?anchor=center&mode=crop&quality=90&width=300&height=375&rnd=133020922900000000
  20. https://www.gsk.com/media/8846/hiv-virus_science.png?anchor=center&mode=crop&quality=90&width=300&height=375&rnd=133020922890000000
  21. https://www.gsk.com/media/7726/nextgen_header.jpeg?anchor=center&mode=crop&quality=90&width=300&height=375&rnd=133003807320000000
  22. https://www.gsk.com/media/8847/stvg_2_2022_smtlab_8_hess.jpeg?anchor=center&mode=crop&quality=90&width=300&height=375&rnd=133020922890000000
  23. https://www.gsk.com/media/8856/stvg_2_2022_smtlab_2_hess-1920x1080px.jpeg?center=0.385,0.40166666666666667&mode=crop&quality=90&width=300&height=375&rnd=133020922900000000
  24. https://www.gsk.com/media/7713/ware_3_2022_prodqc_12_hess.jpeg?center=0.53,0.42&mode=crop&quality=90&width=300&height=375&rnd=133020922900000000
  25. https://www.gsk.com/media/8423/web01-secondary-8-gsk_03_2022_port_8_eagle_light.jpg?anchor=center&mode=crop&quality=90&width=640&height=512&rnd=133002107090000000
  26. https://www.gsk.com/media/8424/web01-secondary-9-gskh_2_2022_smtspc_37_hess.jpg?anchor=center&mode=crop&quality=90&width=640&height=512&rnd=133003731570000000
  27. https://www.gsk.com/media/8425/web01-secondary-10-gskh_3_2022_port_33_hess.jpg?anchor=center&mode=crop&quality=90&width=640&height=512&rnd=133003731730000000
  28. https://www.gsk.com/media/8417/stvg_2_2022_smtlab_17_hess.jpg?anchor=center&mode=crop&quality=90&width=640&height=512&rnd=133003729830000000
  29. https://www.gsk.com/media/8912/mugdha-1280.jpg
  30. https://www.gsk.com/media/8826/gsk_precisionpoint_1280x720_trust_tim.jpg
  31. https://www.gsk.com/media/8824/gsk_precisionpoint_1280x720_trust_fiona.jpg
  32. https://www.gsk.com/media/8823/gsk_precisionpoint_1280x720_trust_andy.jpg
  33. https://www.gsk.com/media/8818/gsk_twist_small_1280x720_employee_alison.jpg
  34. https://www.gsk.com/media/8914/pal-1280.jpg
  35. https://www.gsk.com/media/9545/web14-header-hct_5328.jpg
  36. https://www.gsk.com/media/9546/web15-header-gsk_rix_24_10_18_p_d2_s1_128.jpg
  37. https://www.gsk.com/media/9547/web16-header-stvg_2_2022_port_13_hess.jpg
  38. https://www.gsk.com/media/9548/ocjh1035_gsk-patientshoot1_london-am_0174-2.jpg
  39. https://www.gsk.com/media/9543/ware_3_2022_prodqc_21_hess-1.jpg
  40. https://www.gsk.com/media/9544/ware_3_2022_prodqc_38_hess-1.jpg
  41. https://pbs.twimg.com/media/FgIpYIlXoAIJLq3.jpg
  42. https://pbs.twimg.com/media/Ff_L-_lWIAIzQR-.jpg
  43. https://pbs.twimg.com/media/Ff-woqcWAAEzD23.jpg
  44. https://pbs.twimg.com/media/Ff2PLEFXEAIeGpb.jpg
  45. https://pbs.twimg.com/media/Ffvu_VnWQAMM0oO.jpg
  46. https://pbs.twimg.com/media/FfrA53-X0AU8mjU.jpg
  47. https://pbs.twimg.com/amplify_video_thumb/1583744974251859973/img/n0AZsluFOZc6EGMC.jpg
JavaScript defer
The are 1 javascript resources without the defer attribute.
  1. https://www.gsk.com/assets/js/min/scripts.min.js?v=1507259205
DOM size
There are more than 1,500 DOM nodes.
Security
HTTPS encryption
The webpage uses HTTPS encryption.
The HTML file has https://www.gsk.com/en-gb/ DOM nodes.
Mixed content
There are no mixed content resources on the webpage.
Server signature
The webpage does not have a public server signature.
Unsafe cross-origin links
The webpage has 55 unsafe cross-origin links.
Plaintext email
The webpage does not contain any plaintext emails.
Miscellaneous
Structured data
The webpage has structured data.
      Meta viewport
      The webpage has a meta viewport tag set.
      width=device-width, initial-scale=1
      Character set
      The webpage has a charset value set.
      utf-8
      Sitemap
      No sitemaps found.
      Social
      The webpage has 42 social links.
      Content length
      The webpage has 2,062 words.
      Text to HTML ratio
      The text to HTML ratio is under 10%
      The text to HTML ratio is 5%.
      Inline CSS
      The webpage does not contain inline CSS code.
      Deprecated HTML
      There are no deprecated HTML tags on the webpage.